DJIA 17,827.75 12.81 0.07%
NASDAQ 4,787.32 29.07 0.61%
S&P 500 2,072.83 5.80 0.28%
market minute promo

Geron Corp (NASDAQ: GERN)

3.72 0.13 (3.62%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

GERN $3.72 3.62%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $3.51
Previous Close $3.59
Daily Range $3.50 - $3.79
52-Week Range $1.39 - $6.92
Market Cap $584.8M
P/E Ratio -14.36
Dividend (Yield) $0.00 (0.0%)
Volume 7,201,261
Average Daily Volume 6,416,155
Current FY EPS $0.00

Sector

Healthcare

Industry

Drugs

Geron Corp (GERN) Description

A biopharmaceutical company which is developing first-in-class therapeutic products for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, diabetes and HIV/AIDS. Website: http://www.geron.com/

News & Commentary

3 Healthcare Stocks Short-Sellers Are Wrong About

Short-sellers say these 3 healthcare stocks will fall. Here's why their views might not measure up.

Geron (GERN) Showing Signs Of A Dead Cat Bounce Today

Morning Market Movers

Strong On High Relative Volume: Geron (GERN)

Biotech Stock Roundup: Geron Soars on $935M J&J Deal, Gilead's Harvoni Approved in the EU - Analyst

Biotech Stock Roundup: Geron Soars on $935M J&J Deal, Gilead's Harvoni Approved in the EU - Analyst Blog

Can the Rally in Geron (GERN) Shares Continue? - Tale of the Tape

Strength Seen in Geron (GERN): Stock Surges 19.5% - Tale of the Tape

Strength Seen in Geron (GERN): Stock Surges 19.5% - Tale of the Tape

Geron (GERN) Stock Surges Following Johnson & Johnson Licensing Deal

Geron Collaborates with J&J for Imetelstat - Analyst Blog

Geron's Short Squeeze Is Here

See More GERN News...

GERN's Top Competitors

GERN $3.72 (3.62%)
Current stock: GERN
AMGN $164.72 (1.53%)
Current stock: AMGN
GILD $100.30 (-0.80%)
Current stock: GILD
BIIB $304.92 (-0.16%)
Current stock: BIIB